W. Han, S. Kim, I. Park, D. Kang, S. Kim et al., Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation Institut National du Cancer. Cancer du sein infiltrant non métastatique, Health Technol Assess Winch Engl, vol.411, issue.16, pp.1-144, 2004.

R. Gray, M. Clarke, and D. Cutter, Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

C. Davies, H. Pan, J. Godwin, R. Gray, R. Arriagada et al., Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, The Lancet, vol.381, issue.9869, pp.805-821, 2009.
DOI : 10.1016/S0140-6736(12)61963-1

P. Reddy, W. Zheng, and K. Liu, Mechanisms maintaining the dormancy and survival of mammalian primordial follicles, Trends in Endocrinology & Metabolism, vol.21, issue.2, pp.96-103, 2010.
DOI : 10.1016/j.tem.2009.10.001

T. Pache, J. Wladimiroff, F. De-jong, W. Hop, and B. Fauser, Growth patterns of nondominant ovarian follicles during the normal menstrual cycle, Fertility and Sterility, vol.54, issue.4, 1990.
DOI : 10.1016/S0015-0282(16)53821-7

M. Yamoto, K. Shima, and R. Nakano, Gonadotropin Receptors in Human Ovarian Follicles and Corpora lutea throughout the Menstrual Cycle, Hormone Research, vol.37, issue.1, pp.5-11, 1992.
DOI : 10.1159/000182335

S. Hillier, L. Reichert, V. Hall, and E. , Control of Preovulatory Follicular Estrogen Biosynthesis in the Human Ovary, The Journal of Clinical Endocrinology & Metabolism, vol.52, issue.5, pp.847-56, 1981.
DOI : 10.1210/jcem-52-5-847

L. Giudice, Insulin-like growth factors and ovarian follicular development, Endocr Rev, vol.13, issue.4, pp.641-69, 1992.

E. Mcgee and A. Hsueh, Initial and Cyclic Recruitment of Ovarian Follicles, Endocrine Reviews, vol.21, issue.2
DOI : 10.1210/er.21.2.200

I. Ben-aharon and R. Shalgi, What lies behind chemotherapy-induced ovarian toxicity?, Reproduction, vol.144, issue.2
DOI : 10.1530/REP-12-0121

D. Meirow, H. Biederman, R. Anderson, and W. Wallace, Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity. The Oncologist Toxicity of chemotherapy and radiation on female reproduction, Clin Obstet Gynecol, vol.3153, issue.4, pp.727-766, 2010.

D. Meirow, E. Schiff, C. Dunlop, and R. Anderson, Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data Uses of anti-Müllerian hormone (AMH) measurement before and after cancer treatment in women, J Natl Cancer Inst Monogr. Maturitas, vol.80, issue.343, pp.21-26, 2005.

J. Pérez-fidalgo, S. Roselló, E. García-garré, E. Jordá, P. Martín-martorell et al., Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens, Breast Cancer Research and Treatment, vol.1, issue.2, pp.245-51, 2010.
DOI : 10.1007/s10549-009-0426-x

Y. Tham, K. Sexton, H. Weiss, R. Elledge, L. Friedman et al., The Rates of Chemotherapy-Induced Amenorrhea in Patients Treated With Adjuvant Doxorubicin and Cyclophosphamide Followed by a Taxane, American Journal of Clinical Oncology, vol.30, issue.2, pp.126-158, 2007.
DOI : 10.1097/01.coc.0000251398.57630.4f

O. Ustaalioglu, B. Bilici, A. Kefeli, U. Seker, M. Salepci et al., A retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience, J BUON Off J Balk Union Oncol, 2011.

R. Cooke, M. Jones, D. Cunningham, S. Falk, D. Gilson et al., Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors, British Journal of Cancer, vol.48, issue.11, pp.2399-406, 2013.
DOI : 10.1093/jnci/95.13.971

K. Behringer, H. Mueller, H. Goergen, I. Thielen, A. Eibl et al., Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials, Journal of Clinical Oncology, vol.31, issue.2, pp.231-240, 2013.
DOI : 10.1200/JCO.2012.44.3721

Z. Blumenfeld, How to preserve fertility in young women exposed to chemotherapy?

H. Moore, J. Unger, K. Phillips, F. Boyle, E. Hitre et al., Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy, New England Journal of Medicine, vol.372, issue.10, pp.923-955, 2015.
DOI : 10.1056/NEJMoa1413204

URL : http://www.escholarship.org/uc/item/49n0z7zv

D. Mastro, L. Boni, L. Michelotti, A. Gamucci, T. Olmeo et al., Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapyinduced early menopause in premenopausal women with breast cancer: a randomized trial

H. Chen, J. Li, T. Cui, and L. Hu, Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women
DOI : 10.1002/14651858.CD008018.pub2

E. Elgindy, H. Sibai, A. Abdelghani, and M. Mostafa, Protecting Ovaries During Chemotherapy Through Gonad Suppression, Obstetrics & Gynecology, vol.126, issue.1, pp.187-95
DOI : 10.1097/AOG.0000000000000905

S. Kim, J. Lee, B. Jee, C. Suh, S. Kim et al., Use of Hormonal Protection for Chemotherapy-induced Gonadotoxicity, Clinical Obstetrics and Gynecology, vol.53, issue.4, pp.740-52, 2010.
DOI : 10.1097/GRF.0b013e3181f96cb1

J. Garcia-velasco, J. Domingo, A. Cobo, M. Martínez, L. Carmona et al., Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications, Fertility and Sterility, vol.99, issue.7, pp.1994-2003
DOI : 10.1016/j.fertnstert.2013.02.004

D. Edgar and D. Gook, A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update, pp.536-54, 2012.

L. Rienzi, A. Cobo, A. Paffoni, C. Scarduelli, A. Capalbo et al., Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study, Human Reproduction, vol.27, issue.6, pp.1606-1618
DOI : 10.1093/humrep/des088

A. Cobo, V. Serra, N. Garrido, I. Olmo, A. Pellicer et al., Obstetric and perinatal outcome of babies born from vitrified oocytes, Fertility and Sterility, vol.102, issue.4, pp.1006-1021, 2011.
DOI : 10.1016/j.fertnstert.2014.06.019

A. Baerwald, G. Adams, and R. Pierson, Characterization of Ovarian Follicular Wave Dynamics in Women1, Biology of Reproduction, vol.69, issue.3, pp.1023-1054, 2003.
DOI : 10.1095/biolreprod.103.017772

H. Cakmak, A. Katz, M. Cedars, and M. Rosen, Effective method for emergency fertility preservation: random-start controlled ovarian stimulation, Fertility and Sterility, vol.100, issue.6, p.2013
DOI : 10.1016/j.fertnstert.2013.07.1992

V. Turan, G. Bedoschi, F. Moy, and K. Oktay, Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients Ovarian hyperstimulation syndrome, Fertil Steril. 2013 J Hum, vol.100, issue.6, pp.1681-1686

K. Oktay, I. Türkçüo?lu, and K. Rodriguez-wallberg, GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation, Reproductive BioMedicine Online, vol.20, issue.6
DOI : 10.1016/j.rbmo.2010.03.004

A. Blazquez, J. Guillén, C. Colomé, O. Coll, R. Vassena et al., Empty follicle syndrome prevalence and management in oocyte donors, Human Reproduction, vol.29, issue.10, pp.2221-2228, 2014.
DOI : 10.1093/humrep/deu203

K. Oktay, E. Buyuk, N. Libertella, M. Akar, and Z. Rosenwaks, Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo Cryopreservation, Journal of Clinical Oncology, vol.23, issue.19, pp.4347-53, 2005.
DOI : 10.1200/JCO.2005.05.037

M. Biljan, R. Hemmings, and N. Brassard, The Outcome of 150 Babies Following the

K. Oktay, V. Turan, G. Bedoschi, F. Pacheco, and F. Moy, Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer, Journal of Clinical Oncology, vol.33, issue.22, pp.95-652424, 2005.
DOI : 10.1200/JCO.2014.59.3723

T. Tulandi, J. Martin, R. Al-fadhli, N. Kabli, R. Forman et al., Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate, Fertility and Sterility, vol.85, issue.6, pp.1761-1766, 2006.
DOI : 10.1016/j.fertnstert.2006.03.014

M. Grynberg, E. Hachem, H. De-bantel, A. Benard, J. Le-parco et al., In??vitro maturation of oocytes: uncommon indications, Fertility and Sterility, vol.99, issue.5, pp.1182-1190
DOI : 10.1016/j.fertnstert.2013.01.090

G. Lane, Principles and Practice of Fertility Preservation, pp.1-1

C. Sonigo and M. Grynberg, Maturation in vitro des ovocytes en préservation de la fertilité féminine. Gynécologie Obstétrique Fertil, pp.657-60, 2014.

A. Azim, M. Costantini-ferrando, and K. Oktay, Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Patients With Breast Cancer: A Prospective Controlled Study, Journal of Clinical Oncology, vol.26, issue.16, pp.2630-2635, 2008.
DOI : 10.1200/JCO.2007.14.8700

A. Gremeau, N. Andreadis, M. Fatum, J. Craig, K. Turner et al., In??vitro maturation or in??vitro fertilization for women with polycystic ovaries? A case???control study of 194 treatment cycles, Fertility and Sterility, vol.98, issue.2, pp.355-60, 2012.
DOI : 10.1016/j.fertnstert.2012.04.046

C. Poirot, F. Abirached, M. Prades, C. Coussieu, F. Bernaudin et al., Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet Lond EnglFemale fertility preservation before sterilizing treatment: contribution of ovarian tissue cryopreservation], Feb J Gynécologie Obstétrique Biol Reprod, vol.1137931, issue.98158, pp.588-74717, 2002.

J. Donnez, M. Dolmans, J. Huang, T. Tulandi, H. Holzer et al., Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation, J Assist Reprod Genet Fertil Steril, vol.7789, issue.3, pp.567-72, 2008.

M. Dolmans, V. Luyckx, J. Donnez, C. Andersen, and T. Greve, Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue, Fertil Steril, p.2013

S. Bittinger, S. Nazaretian, D. Gook, C. Parmar, R. Harrup et al., Detection of

J. Smitz, M. Dolmans, J. Donnez, J. Fortune, O. Hovatta et al., Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation, Human Reproduction Update, vol.16, issue.4, pp.395-414, 2010.
DOI : 10.1093/humupd/dmp056

E. Prasath, M. Chan, W. Wong, C. Lim, M. Tharmalingam et al., First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient, Human Reproduction, vol.29, issue.2, pp.276-284
DOI : 10.1093/humrep/det420

P. Uzelac, A. Delaney, G. Christensen, H. Bohler, S. Nakajima et al., Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years Influence of human menopausal gonadotropin on the recruitment of human ovarian follicles, Fertil Steril. Fertil Steril, vol.8354, issue.5, pp.848-52, 1990.

V. Gallot, A. Silva, . Da, V. Genro, M. Grynberg et al., Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome, Human Reproduction, vol.27, issue.4, pp.1066-72, 2012.
DOI : 10.1093/humrep/der479

N. Zhang, C. Hao, L. Zhuang, X. Liu, H. Gu et al., Prediction of IVF/ICSI outcome based on the follicular output rate, Reproductive BioMedicine Online, vol.27, issue.2, pp.147-53
DOI : 10.1016/j.rbmo.2013.04.012

J. Thomas and D. Rubin, Tissue harmonic imaging: why does it work? J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr, pp.803-811, 1998.

J. Domingo, V. Guillén, Y. Ayllón, M. Martínez, E. Muñoz et al., Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment, Fertility and Sterility, vol.97, issue.4, pp.930-934
DOI : 10.1016/j.fertnstert.2012.01.093

R. Quintero, A. Helmer, J. Huang, and L. Westphal, Ovarian stimulation for fertility preservation in patients with cancer, Fertility and Sterility, vol.93, issue.3, pp.865-873, 2010.
DOI : 10.1016/j.fertnstert.2008.10.007

B. Lawrenz, J. Jauckus, M. Kupka, T. Strowitzki, and M. Von-wolff, Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases, Fertility and Sterility, vol.94, issue.7, pp.2871-2874, 2010.
DOI : 10.1016/j.fertnstert.2010.06.054

B. Almog, F. Azem, D. Gordon, D. Pauzner, A. Amit et al., Effects of cancer on ovarian response in controlled ovarian stimulation for??fertility preservation, Fertility and Sterility, vol.98, issue.4, pp.957-60, 2012.
DOI : 10.1016/j.fertnstert.2012.06.007

T. Tulandi and H. Holzer, Effects of malignancies on the gonadal function, Fertility and Sterility, vol.98, issue.4
DOI : 10.1016/j.fertnstert.2012.05.010

M. Devesa, F. Martínez, B. Coroleu, I. Rodríguez, C. González et al., Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram, Journal of Assisted Reproduction and Genetics, vol.91, issue.4, pp.583-591, 2014.
DOI : 10.1007/s10815-014-0183-6

M. Pavone, K. Smith, J. Hirshfeld-cytron, R. Kazer, S. Klock et al., Fertility preservation outcomes may differ by cancer diagnosis, Journal of Human Reproductive Sciences, vol.7, issue.2, pp.111-99, 2014.
DOI : 10.4103/0974-1208.138869

O. Hamdine, M. Eijkemans, E. Lentjes, H. Torrance, N. Macklon et al., Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Mullerian hormone, Human Reproduction, vol.30, issue.1, pp.170-178
DOI : 10.1093/humrep/deu266

R. Vigersky, A. Andersen, R. Thompson, and D. Loriaux, Hypothalamic Dysfunction in Secondary Amenorrhea Associated with Simple Weight Loss, New England Journal of Medicine, vol.297, issue.21, pp.1141-1146, 1977.
DOI : 10.1056/NEJM197711242972103

J. Schenker, D. Meirow, and E. Schenker, Stress and human reproduction, Eur J Obstet Gynecol Reprod Biol. Jun, vol.1645, issue.1, pp.1-8, 1992.

D. Marmor, E. Elefant, C. Dauchez, and C. Roux, Semen analysis in Hodgkin's disease before the onset of treatment. Cancer, pp.1986-1993, 1986.

A. Botchan, R. Hauser, R. Gamzu, L. Yogev, J. Lessing et al., Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma, Human Reproduction, vol.12, issue.1, 1997.
DOI : 10.1093/humrep/12.1.73

U. Rueffer, K. Breuer, A. Josting, B. Lathan, M. Sieber et al., Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment, Annals of Oncology, vol.12, issue.9, pp.1307-1318, 2001.
DOI : 10.1023/A:1012464703805

R. Barr, D. Clark, and J. Booth, Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder. Med Hypotheses, pp.165-173, 1993.